Table 4 Criteria for stopping dobutamine infusion
From: The 20 year evolution of dobutamine stress cardiovascular magnetic resonance
Criteria | Â |
|---|---|
1 | Target heart rate achieved |
2 | Intractable symptoms: severe angina pectoris, severe dyspnea |
3 | New or worsening WMA in ≥ 1 LV segment |
4 | Drop in systolic blood pressure of ≥ 40 mmHg with change in reported symptoms |
5 | Blood pressure increase greater than 240/120 mmHg |
6 | Complex cardiac arrhythmias |
7 | Patient request |